🇺🇸 Norditropin NordiFlex® in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FDA authorised Norditropin NordiFlex® on 20 June 2000

Marketing authorisation

FDA — authorised 20 June 2000

Application: BLA021148
Marketing authorisation holder: NOVO NORDISK INC
Local brand name: NORDITROPIN NORDIFLEX
Indication: INJECTABLE — INJECTION
Status: approved

Read official source →

Frequently asked questions

Is Norditropin NordiFlex® approved in United States?

Yes. FDA authorised it on 20 June 2000.

Who is the marketing authorisation holder for Norditropin NordiFlex® in United States?

NOVO NORDISK INC holds the US marketing authorisation.